Nvidia BioNeMo generative AI platform will be used to accelerate the training of models on proprietary data NEW YORK, June 10, 2024 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient focused biopharmaceutical company, today announced the entry into a joint development agreement with Wise Systems International SRL to leverage artificial intelligence utilizing the BioNeMo AI platform of Nvidia. BioNeMo provides researchers and developers a fast and easy way to build and integrate state-of-the-a ...